COVID-19 treatment Archive — Page 1 of 11

Large group portrait at a retirement celebration, with a seated older man in a dress shirt and tie centered in the front row, surrounded by colleagues and well-wishers in a theater-like room.
June 30, 2025

Coronavirus pioneer Mark Denison bids farewell to VUMC colleagues after remarkable career

The discoveries about coronavirus biology that Denison and his colleagues made were foundational for the rapid validation of antiviral drugs and development of new vaccines that helped bring the COVID-19 pandemic under control.

By Bill Snyder
3D medical illustration of a syringe dispensing small blue and green Y-shaped antibody forms among larger blue and green molecular structures against a red background.
May 8, 2024

Supercomputing redesign of a COVID monoclonal antibody

The approach, which combines high-performance computing, simulation, machine learning and experimental validation, will help keep antibody drugs up to date in the future against highly variable viruses.

By Leigh MacMillan
White disposable surgical mask labeled “COVID-19” on a light blue background.
February 22, 2024

NIH-funded trial to determine if immunomodulation can improve brain and cardiovascular dysfunction in Long COVID

Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.

By Nancy Humphrey
Steven Wall Jr. and Ivelin Georgiev pose in a laboratory, with shelves of research supplies and equipment behind them.
November 6, 2023

Children’s antibodies highly potent against COVID-19: study

Reporting Nov. 6 in Cell Reports Medicine, Ivelin Georgiev, PhD, and colleagues demonstrated that antibodies isolated from children’s blood samples displayed high levels of neutralization and potency against variants of the COVID-19 virus, SARS-CoV-2, even when the children had not previously been exposed to or vaccinated against those variants.

By Bill Snyder
Three-dimensional illustration of a coronavirus particle with a textured gray spherical surface, red spike proteins, and smaller yellow surface structures; blurred particles appear in the background.
August 2, 2023

VUMC receives $28 million to lead national study of COVID-diabetes link

Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes.

By Bill Snyder
Kate Whitley is participating in a free virtual support group at VUMC for those with Long COVID.
June 15, 2023

Virtual support group helps people with Long COVID

In addition to receiving her medical care at Vanderbilt University Medical Center, Kate Whitley is one of about 100 patients participating in a free virtual support group program for those with Long COVID at VUMC.

By Nancy Humphrey